Handle With Care: Replimune Group Inc (NASDAQ: REPL)
Currently, there are 77.01M common shares owned by the public and among those 58.08M shares have been available to trade. The company’s stock has a 5-day price change of 1.15% and 15.67% over the past three months. REPL shares are trading 16.43% year to date (YTD), with the 12-month market performance up to 97.06% higher. […]
Replimune Group Inc (REPL) Outlook Starting To Look Brighter?
Replimune Group Inc (REPL) concluded trading on Thursday at a closing price of $7.66, with 2.66 million shares of worth about $20.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.26% during that period and on Thursday the price saw a gain of […]
Analysts Update Their Price Forecasts For Replimune Group Inc (REPL)
T. Rowe Price Associates, Inc. has recently announced that it has increased stake in Replimune Group Inc (NASDAQ:REPL) by 0.94%. After grabbing 5.67 million shares, the institutional investor is now in possession of 52966.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.60% having worth around $63.35 million. […]
